Yueliang Yao

1.0k total citations
17 papers, 601 citations indexed

About

Yueliang Yao is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Yueliang Yao has authored 17 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Yueliang Yao's work include Glioma Diagnosis and Treatment (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Yueliang Yao is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Yueliang Yao collaborates with scholars based in China, Saudi Arabia and United States. Yueliang Yao's co-authors include Xin Wang, Hao Chen, Wei Chong, Min Mao, Qian Wu, Junying Ma, Si Zhang, Changsheng Zhang, Xue Li and Hongbo Huang and has published in prestigious journals such as Annals of Oncology, Frontiers in Immunology and The Journal of Pathology.

In The Last Decade

Yueliang Yao

16 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yueliang Yao China 11 306 186 171 153 87 17 601
Denise C. Hegan United States 14 415 1.4× 193 1.0× 123 0.7× 59 0.4× 48 0.6× 19 601
Xinhai Zhang China 13 331 1.1× 208 1.1× 136 0.8× 113 0.7× 17 0.2× 26 671
Rosario García Campelo Spain 14 262 0.9× 294 1.6× 143 0.8× 266 1.7× 26 0.3× 66 670
Young‐Choon Moon United States 10 451 1.5× 235 1.3× 140 0.8× 48 0.3× 21 0.2× 23 661
Alessandro Perez Italy 15 301 1.0× 272 1.5× 181 1.1× 206 1.3× 17 0.2× 41 693
Margo P. Cain United States 6 389 1.3× 199 1.1× 236 1.4× 154 1.0× 18 0.2× 6 692
Vincent A. de Weger Netherlands 11 211 0.7× 334 1.8× 67 0.4× 94 0.6× 19 0.2× 26 551
Dongkyoo Park United States 14 545 1.8× 287 1.5× 137 0.8× 90 0.6× 17 0.2× 19 802
Maria Serena Roca Italy 14 457 1.5× 184 1.0× 152 0.9× 104 0.7× 15 0.2× 28 709
Csaba László United States 13 395 1.3× 185 1.0× 192 1.1× 50 0.3× 27 0.3× 20 690

Countries citing papers authored by Yueliang Yao

Since Specialization
Citations

This map shows the geographic impact of Yueliang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueliang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueliang Yao more than expected).

Fields of papers citing papers by Yueliang Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueliang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueliang Yao. The network helps show where Yueliang Yao may publish in the future.

Co-authorship network of co-authors of Yueliang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yueliang Yao. A scholar is included among the top collaborators of Yueliang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueliang Yao. Yueliang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wang, Lei, Kun Zhang, Yueliang Yao, et al.. (2025). Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis. Frontiers in Aging Neuroscience. 16. 1515092–1515092. 5 indexed citations
3.
Yao, Yueliang, Yanxia Wang, Yanxia Wang, et al.. (2022). Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation‐driven medulloblastoma. CNS Neuroscience & Therapeutics. 28(7). 1033–1044. 4 indexed citations
4.
Zhu, Zheng, Jiao Wang, Juan Tan, et al.. (2021). Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target. The Journal of Pathology. 255(4). 374–386. 4 indexed citations
5.
Yao, Yueliang, Mianfu Cao, Min Mao, et al.. (2020). Grincamycin B Functions as a Potent Inhibitor for Glioblastoma Stem Cell via Targeting RHOA and PI3K/AKT. ACS Chemical Neuroscience. 11(15). 2256–2265. 11 indexed citations
6.
Cao, Mianfu, Juan Cai, Yu Shi, et al.. (2019). A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses. Cancer Biology and Medicine. 16(3). 595–605. 41 indexed citations
7.
Chen, Hao, Wei Chong, Qian Wu, et al.. (2019). Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades. Frontiers in Immunology. 10. 1113–1113. 131 indexed citations
8.
Zhang, Chao, Xu Guo, Karl Peltzer, et al.. (2019). The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study. Journal of Cancer. 10(14). 3133–3139. 21 indexed citations
9.
Chen, Hao, et al.. (2019). The immune response‐related mutational signatures and driver genes in non‐small‐cell lung cancer. Cancer Science. 110(8). 2348–2356. 75 indexed citations
10.
Tan, Juan, Mei Liu, Yueliang Yao, et al.. (2018). Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma. The Journal of Pathology. 245(2). 160–171. 11 indexed citations
11.
Zhou, Kai, Yueliang Yao, Zhicheng He, et al.. (2018). VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells. Cell Death and Disease. 9(10). 988–988. 48 indexed citations
12.
Zhao, Qiwen, Yong Lin, Yueliang Yao, et al.. (2017). NDGA-P21, a novel derivative of nordihydroguaiaretic acid, inhibits glioma cell proliferation and stemness. Laboratory Investigation. 97(10). 1180–1187. 8 indexed citations
13.
Liu, Mei, Yong Lin, Xianchao Zhang, et al.. (2017). Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas. Laboratory Investigation. 97(11). 1354–1363. 31 indexed citations
14.
Chen, Yubing, et al.. (2013). Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice. Cancer Cell International. 13(1). 62–62. 51 indexed citations
15.
16.
Ma, Junying, Yongxiang Song, Bo Wang, et al.. (2012). Characterization of a Single Gene Cluster Responsible for Methylpendolmycin and Pendolmycin Biosynthesis in the Deep Sea Bacterium Marinactinospora thermotolerans. ChemBioChem. 13(4). 547–552. 26 indexed citations
17.
Huang, Hongbo, Yueliang Yao, Zhengxiang He, et al.. (2011). Antimalarial β-Carboline and Indolactam Alkaloids from Marinactinospora thermotolerans, a Deep Sea Isolate. Journal of Natural Products. 74(10). 2122–2127. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026